Rebus Holdings, Inc.
Rebus Holdings, Inc. (RBSH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RBSH · as of Jun 9, 2026
Key Statistics
Explore Rebus Holdings, Inc. Data
rbsh stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
rbsh competitorsRBSH
ANTH
CMRA
FPMI
GBIM
NLVVFStock Performance
Full HistoryAbout Rebus Holdings, Inc.
Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for oncology. Its flagship investigational product, RT-AR001, operates as an adenosine receptor antagonist. This compound, whe…
what is rebus holdings, inc. · rbsh stock overview · rebus holdings, inc. company profile · who is rebus holdings, inc. ceo · rbsh OTC · rebus holdings, inc. headquarters · rebus holdings, inc. business segments
About Stock Overview & Key Data
Rebus Holdings, Inc. (RBSH) is a Healthcare company in the Biotechnology industry, listed on OTC since Nov 4, 2009. As of the latest trading session, RBSH stock price is $0.00, with a market capitalization of $3,213. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2022, Rebus Holdings, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Rebus Holdings, Inc. (RBSH) stock price is $0.00. The stock is traded on OTC under the ticker symbol RBSH. The 52-week range is $0.00 – $0.00.